open access

Vol 19, No 4 (2012)
Original articles
Published online: 2012-07-09
Get Citation

Fever in myocardial infarction: Is it still common, is it still predictive?

Michał Kacprzak, Michał Kidawa, Marzenna Zielińska
Cardiol J 2012;19(4):369-373.

open access

Vol 19, No 4 (2012)
Original articles
Published online: 2012-07-09

Abstract

Background: Before introduction of reperfusion therapy, fever was frequently observed in patients with acute myocardial infarction (AMI). Little is known about this symptom during the widespread use of primary percutaneous coronary intervention (pPCI). The aim of this study was to assess, whether body temperature is a predictor of impaired left ventricular systolic function in patients with AMI.

Methods: Our cohort included 171 patients (48 women) aged 57 (51–67) years, admitted due to the first AMI with ST elevation treated with successful pPCI. Standard body temperature measurements were performed twice a day. Left ventricular function was assessed by echocardiography using the wall motion score index (WMSI) and ejection fraction (EF). The following inflammatory response markers were determined on admission: C-reactive protein, fibrinogen and white blood cell count.

Results: Within 48 h of observation the median (1st; 3rd quartiles) peak body temperature was 37.0°C (36.7–37.2°C). A temperature above 37.5°C was observed only in 17 (10%) patients. There was no significant correlation between peak body temperature and any of the determined inflammatory response markers. WMSI was assessed at 1.3 (1.1–1.6), whereas EF at 56% (49–62%). There was no significant correlation between the left ventricular function and peak body temperature or determined markers of inflammation.

Conclusions: In the era of pPCI and aggressive antiplatelet treatment, fever is not a common symptom associated with uncomplicated AMI and thus not correlated with left ventricular function and markers of inflammation.

Abstract

Background: Before introduction of reperfusion therapy, fever was frequently observed in patients with acute myocardial infarction (AMI). Little is known about this symptom during the widespread use of primary percutaneous coronary intervention (pPCI). The aim of this study was to assess, whether body temperature is a predictor of impaired left ventricular systolic function in patients with AMI.

Methods: Our cohort included 171 patients (48 women) aged 57 (51–67) years, admitted due to the first AMI with ST elevation treated with successful pPCI. Standard body temperature measurements were performed twice a day. Left ventricular function was assessed by echocardiography using the wall motion score index (WMSI) and ejection fraction (EF). The following inflammatory response markers were determined on admission: C-reactive protein, fibrinogen and white blood cell count.

Results: Within 48 h of observation the median (1st; 3rd quartiles) peak body temperature was 37.0°C (36.7–37.2°C). A temperature above 37.5°C was observed only in 17 (10%) patients. There was no significant correlation between peak body temperature and any of the determined inflammatory response markers. WMSI was assessed at 1.3 (1.1–1.6), whereas EF at 56% (49–62%). There was no significant correlation between the left ventricular function and peak body temperature or determined markers of inflammation.

Conclusions: In the era of pPCI and aggressive antiplatelet treatment, fever is not a common symptom associated with uncomplicated AMI and thus not correlated with left ventricular function and markers of inflammation.

Get Citation

Keywords

myocardial infarction; fever; body temperature; inflammation

About this article
Title

Fever in myocardial infarction: Is it still common, is it still predictive?

Journal

Cardiology Journal

Issue

Vol 19, No 4 (2012)

Pages

369-373

Published online

2012-07-09

Bibliographic record

Cardiol J 2012;19(4):369-373.

Keywords

myocardial infarction
fever
body temperature
inflammation

Authors

Michał Kacprzak
Michał Kidawa
Marzenna Zielińska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl